Prophylaxis of heterotopic ossification after total hip arthroplasty: A prospective randomized study comparing indomethacin and meloxicam

By Barthel Thomas   Baumann Bernd   Nöth Ulrich   Eulert Jochen  

Acta Orthopaedica Scandinavica, Vol. 73, Iss. 6, 2002-12 ,pp. : 611-614

Informa Healthcare

Access to resources Recommend Favorite

Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: A double-blind randomized trial of 100 patients with 1-year follow-up

By Grohs Josef   Schmidt Maximilian   Wanivenhaus Axel  

Acta Orthopaedica, Vol. 78, Iss. 1, 2007-02 ,pp. : 95-98

Informa Healthcare

Access to resources Recommend Favorite

Preliminary study of rofecoxib (25 mg) in prevention of heterotopic ossification after total hip replacement

By Franchin F.   Sanguineti F.   Caione G.  

Journal of Orthopaedics and Traumatology, Vol. 5, Iss. 2, 2004-08 ,pp. : 77-80

Springer Publishing Company

Access to resources Recommend Favorite

Heterotopic ossification after total hip replacement and the HLA system in the Sicilian population

By Sessa G.   Costarella L.   Mollica R.   Pavone V.  

Journal of Orthopaedics and Traumatology, Vol. 2, Iss. 3, 2002-06 ,pp. : 125-128

Springer Publishing Company

Access to resources Recommend Favorite

No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients

By Neal Bruce C   Rodgers Anthony   Gray Harley   Clark Taane   Beaumont Debbie D   House Tony   Douglas Jan E   Reid Ian R   MacMahon Stephen W  

Acta Orthopaedica Scandinavica, Vol. 71, Iss. 2, 2000-04 ,pp. : 129-134

Informa Healthcare

Access to resources Recommend Favorite